NSB 7.69% 3.6¢ neuroscientific biopharmaceuticals ltd

Ann: Results from Pulmonary Studies, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 89 Posts.
    lightbulb Created with Sketch. 95
    I have to be honest I wasn’t even looking at EmtinB ‘s possible covid treatments - I thought it would play a distant second fiddle to the glaucoma and Alzheimer’s studies. Yet this latest announcement makes me believe that EmtinB may very well have a significant role in covid treatments for those people who are hospitalised. And to state the obvious covid in some form is going to be around for years/forever.
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.6¢
Change
-0.003(7.69%)
Mkt cap ! $5.205M
Open High Low Value Volume
3.8¢ 3.8¢ 3.6¢ $1.413K 38.14K

Buyers (Bids)

No. Vol. Price($)
1 89720 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 75583 1
View Market Depth
Last trade - 15.05pm 13/11/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.